SCHEMBL13431982

SCHEMBL13431982

CN1CCN(C2CCN(C(=O)OCc3ccccc3)CC2)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.64
NPC1 O15118 2/20 0.64
RAB9A P51151 2/20 0.64
CYP2C19 P33261 1/20 0.61
TMEM97 Q5BJF2 9/20 0.57
SIGMAR1 Q99720 9/20 0.57
HTR1A P08908 3/20 0.57
HRH2 P25021 3/20 0.57
HRH1 P35367 3/20 0.57
HRH3 Q9Y5N1 3/20 0.57
ADRA2C P18825 2/20 0.57
ADRA2A P08913 2/20 0.55
ADRA2B P18089 2/20 0.55
HTR2A P28223 2/20 0.55
HTR2C P28335 2/20 0.55
HTR2B P41595 2/20 0.55
DRD1 P21728 1/20 0.55
HTR1B P28222 1/20 0.55
HTR1E P28566 1/20 0.55
SLC6A4 P31645 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13361340 0.95 SMN1; SMN2 (0.60) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL23421452 0.89 SMN1; SMN2 (0.62) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL15407246 0.88 TMEM97 (0.56) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL14529024 0.88 SMN1; SMN2 (0.68) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL1908733 0.88 SMN1; SMN2 (0.57) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL24183442 0.87 SMN1; SMN2 (0.67) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL2607031 0.86 MEN1 (0.66) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL24673292 0.86 MEN1 (0.66) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL30738370 0.86 SMN1; SMN2 (0.65) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97
SCHEMBL13661299 0.86 SMN1; SMN2 (0.65) SMN1; SMN2NPC1RAB9ACYP2C19TMEM97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7696195-B2 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-13 US disclosed